Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

176
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
176
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

217
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
217
Inhaled Medications01:23

Inhaled Medications

236
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
236
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

DSM-5 Changes, COVID-19, and ADHD Diagnosis Rates in Individuals Younger Than 30 Years.

JAMA network open·2026
Same author

Stopping antidepressants safely.

African journal of primary health care & family medicine·2026
Same author

Pharmacotherapy for hypertension in adults 60 years or older.

The Cochrane database of systematic reviews·2025
Same author

Barriers and facilitators to reducing overuse of thyroid function testing: a mixed-methods study.

BMJ quality & safety·2025
Same author

Tramadol (with or without acetaminophen) efficacy and harm: Systematic review and meta-analysis.

Canadian family physician Medecin de famille canadien·2025
Same author

Prevalence of vision impairment and refractive error in rural Nepalese children under five years of age.

Clinical & experimental optometry·2025

相关实验视频

Updated: May 31, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.6K

尽量减少COPD的吸入性皮质类固醇.

Benji Heran1, Thomas L Perry, Ken Bassett

  • 1Department of Anaesthesiology, Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver. bsheran@mail.ubc.ca.

African journal of primary health care & family medicine
|January 23, 2025
PubMed
概括

吸入性皮质类固醇 (ICS) 对慢性阻塞性肺部疾病 (COPD) 提供有限的益处,并带有风险. 现在的指导方针建议将ICS限制在严重的COPD病例中,频繁恶化.

科学领域:

  • 肺部病理学 肺部病理学
  • 药理学 药理学是指药理学的学科.
  • 临床医学 临床医学

背景情况:

  • 吸入性皮质类固醇 (ICS) 用于慢性阻塞性肺病 (COPD) 症状管理.
  • 随机试验显示ICS对COPD死亡率和生活质量的影响有限.
  • 在COPD中使用ICS与潜在的严重危害有关.

研究的目的:

  • 审查吸入性皮质类固醇 (ICS) 治疗慢性阻塞性肺病 (COPD) 的证据.
  • 为了评估ICS治疗COPD患者的益处与风险.
  • 提供有关适当的ICS使用和COPD下药的指导.

主要方法:

  • 随机试验和临床指导方针对COPD的ICS进行审查.
  • 对益处 (症状,恶化) 与危害 (肺炎,骨折) 的分析.
  • 考虑患者因素,如COPD的严重程度和恶化的频率.

主要成果:

  • 在COPD症状和恶化方面,ICS提供了有限的益处.
  • 长期使用ICS会增加严重不良事件的风险,如肺炎和骨折.
  • 指导方针建议将ICS限制在严重的COPD,并频繁恶化.
关键词:
慢性阻塞性呼吸道疾病 慢性阻塞性呼吸道疾病慢性阻塞性肺病 慢性阻塞性肺病皮质类固醇是什么吸入类固醇可以吸入.主要护理是一级医疗保健.治疗药物 治疗药物

更多相关视频

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
00:07

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.6K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.8K

相关实验视频

Last Updated: May 31, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.6K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
00:07

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.6K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.8K

结论:

  • 在轻度的COPD中,ICS的风险往往超过了益处.
  • 停止处方ICS是安全的稳定患者不常见的恶化.
  • 最初的COPD治疗应该优先考虑支气管扩展剂而不是ICS.